QLH-11811
- Generic Name
- QLH-11811
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
- First Posted Date
- 2022-09-26
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT05555212
- Locations
- 🇨🇳
Qilu Pharmaceutical.Co.,Ltd, Jinan, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath